Zurueck zur Suche

Reporte zur Charge U029147

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

11Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NM 6 IN 2 MI 1 IL 1 PA 1

VAERS 2604786

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029147

gering
Staat
MI
Alter
13,0
Geschlecht
F
Eingang
28.03.2023
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

None

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2393590

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029147

gering
Staat
IL
Alter
18,0
Geschlecht
M
Eingang
27.07.2022
Impfdatum
27.07.2022
Beginn
27.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age Wrong product administered

Symptomtext

Case given proquad for recent low titers when he should have been given MMR and Varivax separately due to being out of recommended age range on Proquad.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
unknown
Vorgeschichte
Case stated he is immunocompromised and needed MMR and Varicella vaccines due to recent titers which showed he was lacking immunity.
Andere Medikamente
unknown
Allergien
none known
Vorherige Impfungen
-

VAERS 2364253

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge u029147

gering
Staat
PA
Alter
-
Geschlecht
M
Eingang
11.07.2022
Impfdatum
04.05.2022
Beginn
04.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

no adverse event; a 34 year old male was administered PROQUAD on 5/4/2022; This spontaneous report was received from a registered nurse, referring to a 34 years old male patient. The patient's pertinent medical history, drug reactions/allergies and concomitant therapies were not provided. On 04-MAY-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (0.5 milliliter, quantity 1, lot # u029147, expiration date 16-MAR-2023; strength and route were not provided) for prophylaxis (product administered to patient of inappropriate age). No additional adverse events (AEs) or product quality complaint (PQC) reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2284434

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029147

gering
Staat
NM
Alter
-
Geschlecht
U
Eingang
19.05.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

Pharmacist calling to report multiple patients, a total of 70, were given PROQUAD that had been stored outside of recommended storage range with a non supported disclaimer; No additional Adverse Event details; This spontaneous report was received from a pharmacist regarding to a patient of an unknown age and gender. The pertinent medical history, medical history, previous drug reactions or allergies were not reported. Concomitant medications included sterile diluent (MERCK STERILE DILUENT). On an unknown date, the patient was vaccinated with an improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin (rHA)) (PROQUAD) subcutaneous injection, lot number U029147 with expiration date: 16-MAR-2023, indicated as prophylaxis (dose and route of administration were not provided). (Product storage error). The administered dose of the vaccine experienced a temperature excursion of menus 58 Degree Fahrenheit to 5 Degree Fahrenheit with average of menus 7 Degrees Fahrenheit for 2 hours and below menus 59 Degrees Fahrenheit with average of -65.2 Degrees Fahrenheit for 46 hours. Pharmacist would like to know when the patient could be re-vaccinated. No additional adverse events (AE) reported. This is one case of the several cases received from same reporter.; Sender's Comments: US-009507513-2204USA006370: US-009507513-2204USA006506: US-009507513-2204USA006513:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
MERCK STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2249777

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029147

gering
Staat
NM
Alter
-
Geschlecht
U
Eingang
25.04.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

PROQUAD that had been stored outside of recommended storage range; No additional AE details; This spontaneous report was received from a pharmacist, referring to a patient of unknown age and gender. There was no information about the patient's concurrent conditions or medical history provided. Concomitant therapies included sterile diluent(MERCK STERILE DILUENT). On an unknown date, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (rHA (recombinant Human albumin), lot # U029147, expiration date 16-MAR-2023) for prophylaxis (dose, route and site of administration were not reported). The administered dose of the vaccine experienced a temperature excursion of -58 Degree Fahrenheit to 5 Degree Fahrenheit with average of -7 Degree Fahrenheit for 2 hours and below -59 Degree Fahrenheit with average of -65.2 Degree Fahrenheit for 46 hours. Pharmacist would like to know when the patient could be re-vaccinated. No additional adverse event detail. This is one case of some cases from same reporter.; Sender's Comments: US-009507513-2204USA006370: US-009507513-2204USA006442: US-009507513-2204USA006506:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2249776

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029147

gering
Staat
NM
Alter
-
Geschlecht
U
Eingang
25.04.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

had been stored outside of recommended storage range; No additional AE details; This spontaneous report was received from a pharmacist, referring to a patient of unknown age and gender. There was no information about the patient's concurrent conditions or medical history provided. Concomitant therapies included sterile diluent(MERCK STERILE DILUENT). On an unknown date, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (rHA (recombinant Human albumin), lot # U029147, expiration date 16-MAR-2023) for prophylaxis (dose, route and site of administration were not reported). The administered dose of the vaccine experienced a temperature excursion of -58 Degree Fahrenheit to 5 Degree Fahrenheit with average of -7 Degree Fahrenheit for 2 hours and below -59 Degree Fahrenheit with average of -65.2 Degree Fahrenheit for 46 hours. Pharmacist would like to know when the patient could be re-vaccinated. No additional adverse event detail. This is one case of some cases from same reporter.; Sender's Comments: US-009507513-2204USA006370: US-009507513-2204USA006442:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2244367

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029147

gering
Staat
NM
Alter
1,1
Geschlecht
F
Eingang
20.04.2022
Impfdatum
07.02.2022
Beginn
07.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

"The office had a power outage that required us to move the vaccines to another location. Unfortunately it was determined by the Department of Health and the vaccine manufacturer that the vaccine was believed to be non-viable after this move. No adverse event has been reported."

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
"The office had a power outage that required us to move the vaccines to another location. Unfortunately it was determined by the Department of Health and the vaccine manufacturer that the vaccine was believed to be non-viable after this move. No adverse event has been reported."
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NKA
Vorherige Impfungen
-

VAERS 2244359

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029147

gering
Staat
NM
Alter
1,0
Geschlecht
M
Eingang
20.04.2022
Impfdatum
07.02.2022
Beginn
07.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

"The office had a power outage that required us to move the vaccines to another location. Unfortunately it was determined by the Department of Health and the vaccine manufacturer that the vaccine was believed to be non-viable after this move. No adverse event has been reported."

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
"The office had a power outage that required us to move the vaccines to another location. Unfortunately it was determined by the Department of Health and the vaccine manufacturer that the vaccine was believed to be non-viable after this move. No adverse event has been reported."
Aktuelle Erkrankungen
NONE
Vorgeschichte
1)Small for gestational age fetus - 2)Heart murmur - PDA, 2 small VSDs, PFO 3)Ostium secundum type atrial septal defect - Likely unsealed PFO 4)Congenital nasolacrimal duct obstruction - L more than R 5)Umbilical hernia
Andere Medikamente
MVI HYDROCORTISONE OINTMENT
Allergien
NKA
Vorherige Impfungen
-

VAERS 2244350

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029147

gering
Staat
NM
Alter
4,0
Geschlecht
M
Eingang
20.04.2022
Impfdatum
07.02.2022
Beginn
07.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

"The office had a power outage that required us to move the vaccines to another location. Unfortunately it was determined by the Department of Health and the vaccine manufacturer that the vaccine was believed to be non-viable after this move. No adverse event has been reported."

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
"The office had a power outage that required us to move the vaccines to another location. Unfortunately it was determined by the Department of Health and the vaccine manufacturer that the vaccine was believed to be non-viable after this move. No adverse event has been reported."
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NKA
Vorherige Impfungen
-

VAERS 2206016

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029147

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
30.03.2022
Impfdatum
17.03.2022
Beginn
17.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional AE reported; PROQUAD was administered after a temperature excursion; This spontaneous report was received from a Licensed Practical Nurse referring to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 17-MAR-2022, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA)) (PROQUAD) (strength and route were not reported; lot # U029147, expiration date: 16-MAR-2023) 0.5 milliliter for prophylaxis (product storage error). It was reported that the suspect vaccine was exposed to a temperature of 9 Fahrenheit (F)for a time frame of 1 hour and 25 minutes. There was no previous temperature excursions. No digital data logger was reported. No additional adverse event (AE) information was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2203390

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U029147

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
29.03.2022
Impfdatum
17.03.2022
Beginn
17.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; PROQUAD was administered after a temperature excursion; This spontaneous report was received from a licensed practical nurse and refers to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided. On 17-MAR-2022, the patient was vaccinated with improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (recombinant human albumin (rHA)) (PROQUAD) dose 0.5 milliliter (lot# U029147 verified as valid with expiration date: 16-MAR-2023) (dose number, frequency, route of administration and anatomical location were not provided) for prophylaxis. The aforementioned vaccine underwent a temperature excursion of 9 degrees Fahrenheit for 1 hour and 25 minutes (product storage error). There was no previous temperature excursion. No additional adverse events were reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-